Human stem cell therapy for acute respiratory distress syndrome

Not Applicable

• Conditions: Moderate to severe acute respiratory distress syndrome; Respiratory

• Registration Number: ISRCTN47911040
• Lead Sponsor: Chang Gung Memorial Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-10-26
• Last Update Posted: 8 November 2021
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Adult subjects aged 20-80 years with moderate to severe ARDS, defined as:
1.1. Acute onset
1.2. Bilateral infiltration on chest X-ray
1.3. Pulmonary wedge pressure =18 mmHg
1.4. PaO2/FiO2 =200 mmHg
1.5. PEEP =10 cm H2O
2. Symptoms don’t improve 5 days after traditional or standard therapy

Exclusion Criteria

1. Age <20 or >80 years
2. Pregnancy, breastfeeding
3. Malignancy
4. Autoimmune disease
5. Subjects not suitable for enrollment due to any reason evaluated by the investigator, or patients who have joined other studies

Study & Design

• Study Type: Interventional
• Study Design: Not specified